Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001578563-24-000363

Options or other derivatives

  • CEO and Chairman of the Board acquired 695,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

NEIL GARRY ARTHUR · CEO and Chairman of the Board

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-08-13 Grant or award : show line 1 in the form Stock Option (Right to Buy) +500,400 500,400 D
2024-08-13 Grant or award : show line 2 in the form Restricted Stock Units +194,600 194,600 D
Loading xslF345X05/primary_doc.xml…